JPS62132808A - Hair-forming, hair-growing agent - Google Patents

Hair-forming, hair-growing agent

Info

Publication number
JPS62132808A
JPS62132808A JP27212785A JP27212785A JPS62132808A JP S62132808 A JPS62132808 A JP S62132808A JP 27212785 A JP27212785 A JP 27212785A JP 27212785 A JP27212785 A JP 27212785A JP S62132808 A JPS62132808 A JP S62132808A
Authority
JP
Japan
Prior art keywords
hair
forming
epa
growing agent
growing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP27212785A
Other languages
Japanese (ja)
Other versions
JPH0478606B2 (en
Inventor
Yuzo Fujimoto
祐三 藤本
Takeshi Matsumoto
健 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NITSUSUI SEIYAKU KK
Nissui Pharmacetuical Co Ltd
Original Assignee
NITSUSUI SEIYAKU KK
Nissui Pharmacetuical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NITSUSUI SEIYAKU KK, Nissui Pharmacetuical Co Ltd filed Critical NITSUSUI SEIYAKU KK
Priority to JP27212785A priority Critical patent/JPS62132808A/en
Publication of JPS62132808A publication Critical patent/JPS62132808A/en
Publication of JPH0478606B2 publication Critical patent/JPH0478606B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group

Abstract

PURPOSE:A hair-forming, hair-growing agent having improved hair forming and hair growing effects and low toxicity, containing 5,8,11,14,17-eicosapentaenoic acid or its ester known as a preventive and remedy for thrombosis as an active ingredient. CONSTITUTION:A hair-forming, hair-growing agent containing preferably about 0.01-10wt% based on total amount of hair-forming, hair-growing agent of 5,8,11,14,17-eicosapentaenoic acid shown by the formula or its ester (especially preferably diglyceride or triglyceride). This hair-forming, hair-growing agent is usable in the form of medical cream, medical toilet lotion, medical nourishing agent, hair tonic, hair liquid, hair cream, milky lotion, shampoo, rinse, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規な発毛・育毛剤、更に詳細には、5.8.
11.14.17−エイコサペンタエン酸又はそのエス
テルを有効成分として含有する発毛・育毛料に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention provides a novel hair growth/growth agent, more specifically, 5.8.
11.14.17-Eicosapentaenoic acid or its ester Contains a hair growth/growth agent as an active ingredient.

〔従来の技術およびその問題点〕[Conventional technology and its problems]

5.8゜11.14.17−エイコサペンタエン酸(以
下r EPA Jと称する)は次式0)で表わされる化
合物で、人体における血漿コレステロールを低下させる
作用を有し、血栓症の予防もしくは治療に使用できるこ
とが知られている。
5.8゜11.14.17-Eicosapentaenoic acid (hereinafter referred to as rEPA J) is a compound represented by the following formula 0), which has the effect of lowering plasma cholesterol in the human body and is useful for the prevention or treatment of thrombosis. It is known that it can be used for

また1発毛剤、育毛料としては、従来種々の薬効成分を
含有せしめたものが知られているが、未だ充分な効果を
奏するものは提供されていない。
In addition, although hair growth agents and hair growth agents containing various medicinal ingredients have been known, none have yet been provided with sufficient effects.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者は、gPA及びそのエステルについて、その作
用効果を研究していたところ、これらが発毛及び育毛作
用を有することを見出し1本発明を完成した。
The present inventor was researching the effects of gPA and its esters, and discovered that they have hair growth and hair growth effects, thereby completing the present invention.

すなわち、本発明i、EPA又はそのエステルを有効成
分として含有する発毛・育毛料を提供するものである。
That is, the present invention i provides a hair growth/hair growth agent containing EPA or its ester as an active ingredient.

本発明で使用されるEPA flすでに公知の化合物で
あり、例えば特開昭58−8037号に記載の方法によ
って得られたEPA−エチルエステルをエタノール中苛
性カリで分解することにより高純度のものとして得るこ
とができる。
EPA fl used in the present invention is a already known compound, and is obtained as a highly pure product by decomposing EPA-ethyl ester obtained by the method described in JP-A-58-8037, for example, with caustic potassium in ethanol. be able to.

これは塩の形で使用することもできる。It can also be used in salt form.

また、 EPAのエステルとしてtl、種々のアルコー
ルとのエステルが使用されるが、その中でも、グリセリ
ンとのエステルが好ましい。
Further, as esters of EPA, tl and esters with various alcohols are used, but among them, esters with glycerin are preferred.

このグリセライドとしては次に示すジグリセライド、ト
リグリセライドが挙げられる。
Examples of this glyceride include diglycerides and triglycerides shown below.

1.2.3−トリ(エイコサペンタノイル)グリセライ
ド(EPA−TG) 1.2−ゾ(エイコサペンタエノイル)グリセライド(
1、2−EPA−DC) (Rは水素又はアシル基を示す) 1.3−ゾ(エイコサペンタエノイル)グリセライド(
1、3−EPA−DG ]これらFi1例えばEPAを
ハロゲン化してEPA−ハロゲニドとなし、これにグリ
セリンを反応させることにより製造場れる(特願昭60
−86889号)。これらのグリセライドは一般にそれ
ぞれの混合物として得られるが、これらは単離して単独
で使用することも、また混合物として使用することもで
きる。
1.2.3-Tri(eicosapentanoyl)glyceride (EPA-TG) 1.2-zo(eicosapentaenoyl)glyceride (
1,2-EPA-DC) (R represents hydrogen or an acyl group) 1,3-zo(eicosapentaenoyl)glyceride (
1,3-EPA-DG] These Fi1 can be produced by halogenating EPA, for example, to form EPA-halogenide, and reacting this with glycerin (Patent application 1983).
-86889). These glycerides are generally obtained as a mixture of each, but they can be isolated and used alone or as a mixture.

本発明発毛・育毛料は、常法に従って、薬用クリーム、
薬用化粧水、薬用養毛剤、ヘアトニック、ヘアリキンド
、ヘアクリーム、乳液、シャンプー、リンスなどの通常
の剤型にすればよい。
The hair growth/growth agent of the present invention can be prepared using a medicated cream,
It may be in the usual dosage form such as medicated lotion, medicated hair tonic, hair tonic, hair rekind, hair cream, emulsion, shampoo, conditioner, etc.

配合基剤としては、水、アルコール類、油脂類、界面活
性剤等を使用すればよく、更に他の薬効成分1例えばホ
ルモン類、ビタミン類、アミノ酸類等を配合することも
できる。
As the compounding base, water, alcohols, oils and fats, surfactants, etc. may be used, and other medicinal ingredients such as hormones, vitamins, amino acids, etc. can also be compounded.

本発明において、有効成分の配合量は適宜選択すること
ができるが、通常発毛・青毛料全敞に対して0.01〜
10重量%(以下、単に%で示す)が好ましい。
In the present invention, the blending amount of the active ingredient can be selected as appropriate, but it is usually 0.01 to 0.01 to the total amount of hair growth/blue hair.
10% by weight (hereinafter simply expressed as %) is preferable.

〔発明の効果〕〔Effect of the invention〕

本発明の発毛・育毛料iま、後述の実施例に示す如く、
優れた発毛、育毛効果を有し、しかもEPA及びそのエ
ステルは毒性が極めて低いので安全であるという利点を
有する。
The hair growth/hair growth agent of the present invention, as shown in the examples below,
It has excellent hair growth and hair growth effects, and has the advantage of being safe because EPA and its esters have extremely low toxicity.

〔実施例〕〔Example〕

次に参考例及び実施例を挙げて説明する。 Next, reference examples and examples will be given and explained.

参考例1 (i)EPA−エチルエステル40g(0,121モル
)及び10%KO)lエタノール(KO)Iとして8.
159(0,145モル)〕を仕込み、N、ガス導入下
(150m//分)、75〜76.5℃で1時間還流し
た。反応物を室温まで冷却し。
Reference Example 1 (i) 40 g (0,121 mol) of EPA-ethyl ester and 10% KO) 8.
159 (0,145 mol)] and refluxed at 75 to 76.5° C. for 1 hour while introducing nitrogen and gas (150 m//min). Cool the reaction to room temperature.

10%HC1水にてpH2とし、無機塩が析出するので
水50−を加えて溶かし、n−ヘキサン10〇−及び5
0−で2回抽出した。抽出液を無水硫酸マグネシウムで
乾燥し、溶媒を減圧下40℃で留去し、油状のEPA 
35.99(収率98.1%)を得た。
Adjust the pH to 2 with 10% HC1 water, add 50% of water to dissolve inorganic salts, and add 100% of n-hexane and 5% of the inorganic salt.
Extracted twice with 0-. The extract was dried over anhydrous magnesium sulfate, the solvent was distilled off at 40°C under reduced pressure, and the oily EPA
35.99 (yield 98.1%) was obtained.

(ii)  EPA 35.19 (0,116モル)
にオキザリルクロライド29.59(0,232モル)
をN。
(ii) EPA 35.19 (0,116 mol)
Oxalyl chloride 29.59 (0,232 mol)
N.

ガス導入下室温で滴下した。次いで65〜75℃で4時
間反応させ1反応後過剰のオキザリルクロライドをエバ
ーレータ−で留去した。残留物を減圧下蒸留し、144
℃/1maIH9〜187℃/ 2 mmHfの留分を
集めEPA−クロライド18.78f(収率50.4%
)を得た。
It was added dropwise at room temperature under gas introduction. Next, the mixture was reacted at 65 to 75°C for 4 hours, and after one reaction, excess oxalyl chloride was distilled off using an evaporator. The residue was distilled under reduced pressure to 144
℃/1 maIH9~187℃/2 mmHf fraction was collected and EPA-chloride 18.78f (yield 50.4%
) was obtained.

(i)グリセリン1.811(0,0197モル)。(i) Glycerin 1.811 (0,0197 mol).

キノリン10.89(0,084モル)及びクロロホル
ム80.19を仕込み、これにEPA−クロライド18
.0f(0,056モル)を徐々に滴下した。これを7
2〜80℃で3.5時間還流した。反応液を怜却後1石
油エーテル540−中に注加し、0.5N−硫酸水溶液
30〇−を攪拌下加えて10分間攪拌し、30分間靜装
した。分液し、その上層に5%炭酸カリウム水溶液30
0−を加え、分液した。上層に水300−を加え分液し
、更に上層に飽和食塩水100−を加えて分液し、その
上層を採取した。これを無水硫酸マグネシウムで乾燥後
エバ?レータ−で石油エーテルを留去し。
10.89 (0,084 mol) of quinoline and 80.19 mol of chloroform were charged, and EPA-chloride 18
.. Of (0,056 mol) was gradually added dropwise. This is 7
It was refluxed at 2-80°C for 3.5 hours. After the reaction solution was filtered, it was poured into 540 ml of petroleum ether, 300 ml of a 0.5N aqueous sulfuric acid solution was added under stirring, stirred for 10 minutes, and kept quiet for 30 minutes. Separate the layers and add 30% of 5% potassium carbonate aqueous solution to the upper layer.
0- was added and the liquids were separated. 300 ml of water was added to the upper layer to separate the layers, and 100 ml of saturated saline was added to the upper layer to separate the layers, and the upper layer was collected. After drying this with anhydrous magnesium sulfate? Petroleum ether is distilled off using a rotor.

油状物15.159を得た。15.159 of an oil was obtained.

シリカゲル500gを特級ベンゼンを用いてガラスカラ
ムに充填し、これに上記油状物10gを特級ベンゼン1
00−に溶かしたものを注加した。次いで同ベンゼン8
tを用いて溶出し、300−ずつの分画を採取した。
A glass column was filled with 500 g of silica gel using special grade benzene, and 10 g of the above oil was added to the column using special grade benzene.
00- was added. Then the same benzene 8
Elution was performed using t and 300-fraction fractions were collected.

この分画について、TLC(キーセルグル60F2展開
溶媒:ベンゼン、確認:I、ペイ、Q  )により溶出
物を確認し、同−溶水物を集め、減圧下溶媒を留去し1
次の物質を得た。
Regarding this fraction, the eluate was confirmed by TLC (Kieselglu 60F2 developing solvent: benzene, confirmation: I, Pei, Q), the eluate was collected, and the solvent was distilled off under reduced pressure.
The following material was obtained.

実施例I EPAナトリウム(EPA純度96.8%)を50%エ
タノールに1%の割合に混じたものを検体とした。なお
検体は使用の都度新たに、4.   混合調製して用い
た。対照には50%エタノ−ルを使用した。
Example I A sample was prepared by mixing EPA sodium (EPA purity 96.8%) in 50% ethanol at a ratio of 1%. The specimen should be freshly prepared each time it is used.4. They were mixed and prepared before use. 50% ethanol was used as a control.

ウィスター系4之 10匹として2群.計20匹を使用した。ラットの背部
被電をを椎の両側で,それぞれ4X4CIIL”の広嘔
にシェーバ−を用いて除毛した。除毛部中央に3×3α
2の区画を油性ペンで描記し、被験液の塗布部位とした
。上記手技の翌日から1日朝夕の2回,連続7日間、検
体又は対照液を表1の配置で1区画当り0、2−を塗布
し,8日目に被電の伸長度および毛虫の状態を実体顕微
鏡下に観察した。被電の伸長度は表2の基準により指数
化した。
2 groups of 4 to 10 Wistar type animals. A total of 20 animals were used. Hair was removed from the back of the rat using a shaver on both sides of the vertebrae, each measuring 4 x 4 CIIL.
Section 2 was drawn with an oil-based pen to serve as the area to which the test solution was applied. From the day after the above procedure, the specimen or control solution was applied twice in the morning and evening on the 1st for 7 consecutive days at 0 and 2- per section in the arrangement shown in Table 1, and on the 8th day, the degree of elongation of the electrified object and the condition of the caterpillars were applied. was observed under a stereomicroscope. The degree of elongation of the electrically conductive material was expressed as an index based on the criteria shown in Table 2.

表1 検体塗布部位配置 表2 被電伸長度指数化基準 また、塗布部位の差を消去する目的で,1群と1群では
CとEの配置を交叉略せ、全ての個体にc,gの両検体
を塗布し、個体差の均等化を計った。
Table 1 Specimen Application Site Arrangement Table 2 Standard for Electrified Elongation Index In addition, in order to eliminate the difference in application sites, the placement of C and E was omitted in Group 1 and Group 1, and C and G were applied to all individuals. Both samples were applied to equalize individual differences.

その結果を表3に示す。The results are shown in Table 3.

以下余白 表3に示すように、E塗布部位の被電はCと比較して有
意な伸長を示した。また、顕微鏡下での観察では背部除
毛全般の基礎的生毛の状態では被電の先端部がシェービ
ングによる断裂端の形状を示したのに対し、伸長系の大
部分は先端鋭利な新生毛の形状が観察された。
As shown in Margin Table 3 below, the electrification of the E-coated area showed significant elongation compared to C. In addition, when observed under a microscope, the tip of the electrified hair showed the shape of a torn end due to shaving in the basic condition of hair removed from the back in general, whereas most of the elongated hair showed the shape of new hair with a sharp tip. shape was observed.

以上の結果より、 EPAす) IJウム塩は被電の伸
長を促進し、特に毛の新生伸長を促進することが示でれ
た。
From the above results, it was shown that EPA (IJ) salt promotes the elongation of electrified hair, and particularly promotes the new growth and elongation of hair.

実施例2 ウィスター系雄性ラット(40週令)を1群5匹の2群
、計10匹を使用した。エーテル麻酔下に、背部被電を
正中線の左、右側それぞれに4 cm X 8cmの広
さにシェービングし、3 cx X 3 cmの区画を
片側に2区画1両側が対照的になるように計4区画を油
性ペンで描記した。この手技の翌日より表4の各検体を
表5の配置&により、1日2回、連続10日日間型部の
各区画内に1区画当り、0.2−を塗布した。11日目
に表2の判定基準に基ずき被電の伸長程度を調べた。
Example 2 A total of 10 male Wistar rats (40 weeks old), 2 groups of 5 rats per group, were used. Under ether anesthesia, the dorsal area was shaved to the left and right sides of the midline in an area measuring 4 cm x 8 cm, and two sections of 3 cm x 3 cm were placed on one side, each side being symmetrical. Four sections were drawn with an oil-based pen. From the next day after this procedure, each specimen in Table 4 was applied at a concentration of 0.2-2% per section in each section of the mold section twice a day for 10 consecutive days using the arrangement shown in Table 5. On the 11th day, the degree of elongation of the electrified object was examined based on the criteria shown in Table 2.

表4 検体 * 1  apA−c : zph−TaとgPA−D
Gの比が55:45で、脂肪酸分析におい てEPA 90.3%を含有する。
Table 4 Specimen*1 apA-c: zph-Ta and gPA-D
G ratio is 55:45 and contains 90.3% EPA in fatty acid analysis.

*2 被験検体は塗布直前に混合調製して使用した。*2 The test specimen was mixed and prepared immediately before application.

表5 検体塗布部位配置 その結果を表6に示す。Table 5 Sample application site arrangement The results are shown in Table 6.

表6に示すEPA−Gの枝毛伸長度を各塗布区画毎に指
数化すると表7のとおりであり、CとEの間にはp<o
、osで有意差が認められた。
The degree of elongation of split ends of EPA-G shown in Table 6 is expressed as an index for each application section as shown in Table 7, and between C and E, p<o
, a significant difference was observed in os.

表7EPA−Gの波型伸長促進効果 以上Table 7 Wave-shaped elongation promoting effect of EPA-G that's all

Claims (1)

【特許請求の範囲】 1、5,8,11,14,17−エイコサペンタエン酸
又はそのエステルを有効成分として含有する発毛・育毛
料。 2、5,8,11,14,17−エイコサペンタエン酸
のエステルがジグリセライド又はトリグリセライドであ
る特許請求の範囲第1項記載の発毛・育毛料。
[Scope of Claims] A hair growth/growth agent containing 1,5,8,11,14,17-eicosapentaenoic acid or its ester as an active ingredient. The hair growth/growth agent according to claim 1, wherein the ester of 2,5,8,11,14,17-eicosapentaenoic acid is diglyceride or triglyceride.
JP27212785A 1985-12-03 1985-12-03 Hair-forming, hair-growing agent Granted JPS62132808A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27212785A JPS62132808A (en) 1985-12-03 1985-12-03 Hair-forming, hair-growing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27212785A JPS62132808A (en) 1985-12-03 1985-12-03 Hair-forming, hair-growing agent

Publications (2)

Publication Number Publication Date
JPS62132808A true JPS62132808A (en) 1987-06-16
JPH0478606B2 JPH0478606B2 (en) 1992-12-11

Family

ID=17509464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27212785A Granted JPS62132808A (en) 1985-12-03 1985-12-03 Hair-forming, hair-growing agent

Country Status (1)

Country Link
JP (1) JPS62132808A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334585A2 (en) * 1988-03-23 1989-09-27 Unilever Plc Cosmetic composition
US6762203B2 (en) 1999-08-03 2004-07-13 Kao Corporation Oil composition
US6956058B2 (en) 2001-04-26 2005-10-18 Kao Corporation Method for improving insulin resistance
JP2010083893A (en) * 2008-09-30 2010-04-15 Symrise Gmbh & Co Kg Extract of isochrysis sp

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334585A2 (en) * 1988-03-23 1989-09-27 Unilever Plc Cosmetic composition
US6762203B2 (en) 1999-08-03 2004-07-13 Kao Corporation Oil composition
US6852758B2 (en) 1999-08-03 2005-02-08 Kao Corporation Oil composition
US6956058B2 (en) 2001-04-26 2005-10-18 Kao Corporation Method for improving insulin resistance
JP2010083893A (en) * 2008-09-30 2010-04-15 Symrise Gmbh & Co Kg Extract of isochrysis sp
US10463891B2 (en) 2008-09-30 2019-11-05 Symrise Ag Extracts of Isochrysis sp.

Also Published As

Publication number Publication date
JPH0478606B2 (en) 1992-12-11

Similar Documents

Publication Publication Date Title
JPS63192703A (en) External agent for skin
US5147859A (en) Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them
JPH04327563A (en) Ceramide, method of manufacturing same and cosmetic composition
ITMI991884A1 (en) COMPOSITIONS FOR SKIN CARE AND THEIR USE IN CARE FOR DAMAGED SKIN
EP0554897B1 (en) Sterol derivative, process for producing the same and dermatologic external preparation
EP0084341B2 (en) Emulsion-type composition for external use
JP3343208B2 (en) Lipid composition having liquid crystal structure
JPS5923320B2 (en) Branched fatty acid cholesteryl ester
CA2032733A1 (en) Topical pharmaceutical compositions
JPH08134026A (en) Salt of aminoalcohol and medicinal prescription containing same
KR100545836B1 (en) Cosmetic composition for skin irritation relief containing nanoliposomes of intracellular lipid components
JPH04257517A (en) Dephenyl compound for inhibiting arachidonic acid metabolic action and use thereof for drug composition
JP2000109409A (en) Acne prevention and amelioration agent
KR940011454B1 (en) Amide derivatives and external medicament comprising same
JPS62132808A (en) Hair-forming, hair-growing agent
JP3400666B2 (en) Skin protective agent
JPS61204109A (en) Emulsion-type composition for external use
JP2514995B2 (en) Composition for promoting absorption of substance by transdermal and transmucosal
JPS6027647B2 (en) Cosmetics containing branched fatty acid cholesteryl ester
JPS617205A (en) Cell activator
JPH0692293B2 (en) External skin preparation
JPH06145123A (en) Amide derivative and its production intermediate, and skin external preparation containing the amide derivative
JP3833724B2 (en) Wrinkle improver
JP2741143B2 (en) External preparation for skin
JP2691608B2 (en) Pack cosmetics